Loading
Life sciences · Interventional Study
ClinicalTrials.gov · October 1, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Interventional Study.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT07090005). This is a study registration, not published results. Lead sponsor: Nitinotes Surgical Ltd.. Recruitment status: RECRUITING. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 184 participants (ESTIMATED). Conditions: Obesity, Overweight. Interventions: DEVICE: EndoZip System; DEVICE: OverStitch Endoscopic Suturing System (ESG). Primary outcome measures: Mean percent of total body weight loss (%TBWL) after 12 months in Group A patients versus Group B. , 12 months; Percentage of patients in Group A with a reduction in %TBWL of at least 5% at 12 months , 12 months. Brief summary: evaluation of the EndoZip system procedure compared to the Apollo ESG procedure in obese patients.